2014 Pediatric Pharmacogenomics and Personalized Medicine Conference

Kansas City, Missouri
Thursday, April 10, 2014


2014 Pediatric Pharmacogenomics and Personalized Medicine Conference
Thursday, April 10, 2014 - Friday, April 11, 2014

Children's Mercy
2401 Gillham Road
Kansas City, Missouri 64108
United States


Dear Colleagues,  

It gives us great pleasure to welcome you to the Fifth Annual Pediatric Pharmacogenomics and Personalized Medicine Conference.  This meeting  will be focused on Genome Based Therapeutics in Children.  This sharing of knowledge will serve as a forum for world leaders in the field to come together to contribute to the safe and effective treatment of children, our most vulnerable population.  We have developed an excellent program featuring speakers from around the world to share with you the latest opportunities centering around clinical applications, bioethics, bioinformatics, and infrastructure development of pediatric personalized medicine programs.  Take a few moments to browse the program to confirm our assertions that the presentations feature a world-class group of experts that will make excellent use of our brief time together.  Please join us as we celebrate the offerings of science and exchanges that will affect our practices long after the end of this meeting in the form of new energy and ideas that will boost our efforts to improve the health of our children.  As we continue to expand our initiatives here at Children’s Mercy, we also continue to expand our collaborative efforts with other researchers regionally, nationally and internationally.  We hope you, our colleagues, will join us in these efforts.  We expect attendance will be strong and look forward to seeing you in April in Kansas City, MO.  


J Steven Leeder, PharmD, PhD
Gregory L Kearns, PharmD, PhD
John Lantos, MD

Session Topics Include:

"Personalized/Individualized Medicine: The Role of Networks and Academic Parternships"
"Pediatric ADRs"
"The role of pharmacogenomics in determining the effect of drugs used to treat asthma and allergic disease"
"The role of pharmacogenomics in determining the effect of drugs used in cancer and/or infectious disease"
"ADHD and Autism pharmacogenetics"
"EMA position on the inclusion of pharmacogenetic/genomic data into product labels"
"The clinical use of genetics in pediatrics"
"Genetic screening (either prenatal or postnatal) to develop enhancement programs"
"Electronic Health Record-based Phenotyping in a Pediatric Setting: A Case Study for Drug Induced Liver Injury."
"Physiologically-Based Pharmacokinetic (PBPK) Models in Children:  Data In, Knowledge Out"
"Clinical Use of Whole Genome Sequencing:  The Challenges Ahead"

Other Conference Speakers:

Dick Weinshilboum, MD               
Mayo Clinic 
Donald R  Mattison, MD
Risk Sciences International Ottawa, ON

Casey L Overby, PhD   
University of Maryland School of Medicine
Bridgette L Jones, MD                  
Allergy/Immunology & Clinical Pharmacology 
Howard L McLeod, PharmD        
Moffitt Cancer Center, Florida
Erika Nurmi, MD, PhD                   
Semel Institute for Neuroscience, University of California

Agnes Saint-Raymond, MD           
Ethics Head of Programme Board European Medicines Agency
Steve Joffe, MD, MPH                   
University of Pennsylvania, Perelman School of Medicine
Hank Greely, JD                                 
Sanford Law School
Sigrid Sterckx, Professor    
BioEthics Institute Ghent, Ghent University and Vrije Universiteit Brussel 
Andrea Edginton, PhD
School of Pharmacy at the University of Waterloo


Children’s Mercy is accredited by the Missouri State Medical Association to provide continuing medical education for physicians.

Children’s Mercy designates this live educational activity for a maximum of 9.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Following the conference, you will receive an e-mail message containing a link to an online evaluation form. Upon completion and receipt, you will receive a copy of your CME certificate via e-mail.


Contact Information

    For Poster Presentation
    No later than March 7, 2014

    Send Abstracts to:  mclifton@cmh.edu


     National Institutes of Health


    Funding for this conference was made possible [in part] by 2R13HD065386 from National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government

    Ms Melonie Clifton
    Clinical Pharmacology & Therapeutic Innovation 
    Center for Pediatric Genomic Medicine 

    Children's Mercy   
    2401 Gillham Road
    Kansas City, MO 64108
    Phone: 816-234-3088
    Fax: 816-855-1958
    E-mail: mclifton@cmh.edu
    Website: www.childrensmercy.org

Payment Instructions

  • You may register online using your VISA, MasterCard, American Express, or Discover. You will receive written confirmation and receipt of your successful registration via email.


    Early Bird Registration
      (now thru Feb 28)

        Full Conference $300.00
        Friday only $100.00
        Students and Trainees $100.00
    Regular Registration
      (Feb 28 to Mar 14)
        Full Conference Registration: $350
        Friday only $125.00
        Students and Trainees: $150

    Late Registration
      (Mar 14 to close of conference) 
        Full Conference Registration: $400
        Friday Only $150.00
        Students and Trainees: $200

    Note: Registration fees are waived for employees of Children's Mercy.
© 2018
Quick, easy and affordable online event registration and event management software for all event sizes.